MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹1,515 Cr | ₹1,705 Cr | ₹8.68 Cr | ₹48 Cr | ₹16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹1,515 Cr |
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹8.68 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹16 Cr |
How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,515 Cr | -11.11 | |
| Mar2025 | ₹1,705 Cr | 19,538.48 | |
| Mar2024 | ₹8.68 Cr | -81.74 | |
| Mar2023 | ₹48 Cr | 191.02 | |
| Mar2022 | ₹16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹96,233.1 Cr | -2.9% | 2.3% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -2.9% |
2.3% |
-3.3% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses